Short term outcomes of helical tomotherapy during concurrent chemoradiotherapy for advanced cervical cancer

Mabuchi,Yasushi; Takiguchi,Yoshihiro; Yahata,Tamaki; Mizoguchi,Mika; Sasaki,Noriyuki; Ota,Nami; Minami,Sawako; Ino,Kazuhiko

doi:10.3892/mco.2019.1806

March-2019 Volume 10 Issue 3

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

March-2019 Volume 10 Issue 3

Full Size Image

Article

Short term outcomes of helical tomotherapy during concurrent chemoradiotherapy for advanced cervical cancer

Authors:
- Yasushi Mabuchi
- Yoshihiro Takiguchi
- Tamaki Yahata
- Mika Mizoguchi
- Noriyuki Sasaki
- Nami Ota
- Sawako Minami
- Kazuhiko Ino
View Affiliations / Copyright

Affiliations: Department of Obstetrics and Gynecology, Wakayama Medical University, School of Medicine, Wakayama, Wakayama 641‑0012, Japan
Pages: 382-386
|
Published online on: January 23, 2019

https://doi.org/10.3892/mco.2019.1806
Expand metrics +

Abstract

The aim of the present study was to clarify the feasibility and efficacy of helical tomotherapy during concurrent chemoradiotherapy for treating cervical cancer. The medical records of 13 patients who underwent oncurrent chemoradiotherapy using helical tomotherapy for cervical cancer at Wakayama Medical University Hospital between 2013 and 2015 were retrospectively reviewed. A total of 15 patients who underwent oncurrent chemoradiotherapy using conventional radiotherapy (CRT) between 2008 and 2013 at our institution were also examined for comparison. The median age of patients treated with helical tomotherapy was 60 (range, 35‑71), and the median age of patients treated with CRT was 57 (range, 43‑77). The median follow‑up period was 27 months (range, 3‑46) in the tomotherapy group and 35 months (range, 7‑88) in the CRT group. The frequency of G3/4 thrombocytopenia in the tomotherapy group was significantly higher than that in the CRT group (P=0.049). However, the platelet count spontaneously recovered without transfusion. There were no significant differences between the groups in terms of frequency of G3/4 neutropenia, diarrhea or late intestine injury. The rate of complete response in the tomotherapy group and the CRT group was 84.6 and 73.3%, respectively, and there was no significant difference in the response rate between the groups. There were no significant differences in the progression‑free survival or progression‑free rate in the irradiation field between the groups. Adverse events from concurrent chemoradiotherapy using helical tomotherapy were acceptable and clinically controllable. The present results suggest that helical tomotherapy is efficient during concurrent chemoradiotherapy for treatment of advanced cervical cancer.

View Figures

View References

1	Keys HM, Bundy BN, Stehman FB, Muderspach LI, Chafe WE, Suggs CL III, Walker JL and Gersell D: Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N Engl J Med. 340:1154–1161. 1999. View Article : Google Scholar : PubMed/NCBI
2	Tseng CJ, Chang CT, Lai CH, Soong YK, Hong JH, Tang SG and Hsueh S: A randomized trial of concurrent chemoradiotherapy versus radiotherapy in advanced carcinoma of the uterine cervix. Gynecol Oncol. 66:52–58. 1997. View Article : Google Scholar : PubMed/NCBI
3	Peters WA III, Liu PY, Barrett RJ II, Stock RJ, Monk BJ, Berek JS, Souhami L, Grigsby P, Gordon W Jr and Alberts DS: Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J Clin Oncol. 18:1606–1613. 2000. View Article : Google Scholar : PubMed/NCBI
4	Kirwan JM, Symonds P, Green JA, Tierney J, Collingwood M and Williams CJ: A systematic review of acute and late toxicity of concomitant chemoradiation for cervical cancer. Radiother Oncol. 68:217–226. 2003. View Article : Google Scholar : PubMed/NCBI
5	Gandhi AK, Sharma DN, Rath GK, Julka PK, Subramani V, Sharma S, Manigandan D, Laviraj MA, Kumar S and Thulkar S: Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: A prospective randomized study. Int J Radiat Oncol Biol Phys. 87:542–548. 2013. View Article : Google Scholar : PubMed/NCBI
6	Schwarz JK, Wahab S and Grigsby PW: Prospective phase I–II trial of helical tomotherapy with or without chemotherapy for postoperative cervical cancer patients. Int J Radiat Oncol Biol Phys. 81:1258–1263. 2011. View Article : Google Scholar : PubMed/NCBI
7	Chang AJ, Richardson S, Grigsby PW and Schwarz JK: Split-field helical tomotherapy with or without chemotherapy for definitive treatment of cervical cancer. Int J Radiat Oncol Biol Phys. 82:263–269. 2012. View Article : Google Scholar : PubMed/NCBI
8	Jouglar E, Thomas L, de la Rochefordière A, Noël G, Le Blanc-Onfroy M, Delpon G, Campion L and Mahé MA: Toxicity and early clinical outcomes in cervical cancer following extended field helical tomotherapy to para-aortic lymph nodes. Cancer Radiother. 20:794–800. 2016. View Article : Google Scholar : PubMed/NCBI
9	Marnitz S, Lukarski D, Köhler C, Wlodarczyk W, Ebert A, Budach V, Schneider A and Stromberger C: Helical tomotherapy versus conventional intensity-modulated radiation therapy for primary chemoradiation in cervical cancer patients: An intraindividual comparison. Int J Radiat Oncol Biol Phys. 81:424–430. 2011. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Short term outcomes of helical tomotherapy during concurrent chemoradiotherapy for advanced cervical cancer

This article is mentioned in:

Abstract

Figure 1

Figure 2

Related Articles